Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 1 080,97 €, with a 24-hour trading volume of 3,12B €. The asset's market cap is 963,94B €, after moving 1.81% in the last day.
Tokenized Eli Lilly And Co is trading at 1 077,88 €, with a tokenized market cap of 41,51M € and a 24-hour trading volume of 2,04M €. The tokenized asset has moved 0.82% in the past 24 hours.